Insider trades
Daphne Karydas, Director of Mineralys Therapeutics MLYS, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $839.8K. The latest trade was on 06/17.
Daphne Karydas
Director
- Company
- Mineralys Therapeutics MLYS
- First filing
- 23/09/14
- Trades
- 19 trades
- Buys / sales
- 0 / 4
- 12-month net buying
- −$839.8K
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/17 | 06/17 | 3,000 sh | $25.00 | $75,000 | −32.6% | |
| Open-market sale10b5-1 plan | 03/31 | 04/02 | 3,000 sh | $25.00 | $75,000 | −32.6% | |
MLYS | Open-market sale | 25/11/13 | 25/11/13 | 15,000 sh2 trades | $45.99avg. | $689,836.75 | −100.0% |